“rhythm-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Rhythm Pharma’s Obesity Drug Hits Phase 3 Goals, FDA Filing Planned 08/07/19 Boston
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan 05/02/19 Texas
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering 04/18/19 Texas
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC 02/11/19 Texas
Millendo Therapeutics Goes Public With OvaScience Reverse Merger 08/09/18 Detroit Ann Arbor
Roundup: Genomenon, Develop(her), QL Demo Day, MBA Summit & More 04/26/18 Detroit Ann Arbor
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO 09/06/17 Boston
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Acelity Sells LifeCell Tissue Repair Unit to Allergan for $2.9B 12/20/16 Texas
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
Allergan Snags Rhythm’s Diabetes-Related GI Drug for $200M 10/27/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
After Zafgen Abandons Prader-Willi Drug, Could Rhythm Offer Hope? 07/28/16 Boston
Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure 07/18/16 San Diego
Rhythm Pharmaceuticals Lands $40,000,000 Series A Funding 12/11/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics 10/22/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Page 1 of 2 next page »